PATENT CLAIM ANALYSIS

Application Number: 15879900
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-01
Patent Classification: ["424", "133100"]

Abstract:
The invention features methods for preventing or treating CGRP associated disorders such as vasomotor symptoms and/or headaches (e.g., migraine, cluster headache, and tension headache) by administering an anti-CGRP antagonist antibody. Compositions for use in the disclosed methods are also provided. Antagonist antibody G1 and antibodies derived from G1 directed to CGRP are also described.

Claim (Index 5):
The method of  claim 3 , wherein the migraine headache is episodic migraine headache.

Metadata:
- Claim Count in Document: 60.0
- Percentile: 86.0
- Lexical Diversity: 1.26531
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14711705', '14664715', '15712444', '13179846', '14719015']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6752890523752372
- 35 USC 102 Novelty (BERT): 0.6545043414561178
- Combined Prediction Score: 0.6732105812833252
- Mean Citation Score: 693.865292
- Max Citation Score: 737.6649
- Similarity Product: 567.2664579717638

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test